e.g. Tata motors, Reliance MF, 500570
NORRIS MEDICINES LTD. - Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th May, 2024 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
Download announcement < Back
29 May 2024
1. Approval of Audited Standalone Financial Results for the quarter and year ended March 31, 2024 as per Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. 2. Approval of statement of Assets and liabilities for the year ended March 31, 2024. 3. Also note that M/s.Bahedia &amp; Associates, Statutory auditors of the Company have issued the Audit report for the financial year ended on March 31, 2024 with unmodified opinion pursuant to regulation 33(3)(d) of the SEBI(LODR), Regulations, 2015.
View all announcements for NORRIS MEDICINES LTD. Source: BSE India